NCT00004397View on ClinicalTrials.gov

Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 1998

Study Completion Date

May 31, 2000

Conditions
Porphyria
Interventions
DRUG

heme arginate

DRUG

tin mesoporphyrin

All Listed Sponsors
collaborator

University of Texas

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004397 - Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria | Biotech Hunter | Biotech Hunter